

(Sharecast News) - Speciality pharmaceuticals company Diurnal Group announced a proposed conditional placing with institutional investors to raise up ...


Diurnal Raises GBP8 Million For Product Development, Commercialisation


IN BRIEF: Diurnal Gets US FDA Approval For Alkindi Sprinkle


IN BRIEF: Diurnal Annual Revenue Climbs And Loss Narrows


IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec


UK Earnings, Trading Statements Calendar - Next 7 Days


IN BRIEF: Diurnal Inks Two European Marketing And Distribution Pacts


(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced two further European market and distribution agreements for its products ...